
{
    "credit": [
        {
            "email": "seq-info@lanl.gov",
            "typeEntity": "Person",
            "typeRoles": [
                "Primary contact"
            ],
            "url": "http://www.mybiosoftware.com/www.lanl.gov"
        }
    ],
    "documentation": [
        {
            "type": "GENERAL",
            "url": "https://www.hiv.lanl.gov/content/sequence/TUTORIALS/Tutorials.html"
        }
    ],
    "function": [
        {
            "operation": [
                {
                    "term": "Design",
                    "uri": "http://edamontology.org/operation_2430"
                }
            ]
        }
    ],
    "labels": {
        "language": [
            "Python"
        ],
        "operatingSystem": [
            "Linux",
            "Windows",
            "Mac"
        ],
        "toolType": [
            "Web application"
        ],
        "topic": [
            {
                "term": "Proteins",
                "uri": "http://edamontology.org/topic_0078"
            },
            {
                "term": "Immunology",
                "uri": "http://edamontology.org/topic_0804"
            },
            {
                "term": "Allergy, clinical immunology and immunotherapeutics",
                "uri": "http://edamontology.org/topic_3400"
            }
        ]
    },
    "link": [
        {
            "type": "SOFTWARE_CATALOGUE",
            "url": "http://www.mybiosoftware.com/mosaic-vaccine-designer-1-2-11-generate-candidate-vaccine-protein-cocktails-optimize-coverage.html"
        }
    ],
    "publication": [
        {
            "abstract": "HIV-1/AIDS vaccines must address the extreme diversity of HIV-1. We have designed new polyvalent vaccine antigens comprised of sets of 'mosaic' proteins, assembled from fragments of natural sequences via a computational optimization method. Mosaic proteins resemble natural proteins, and a mosaic set maximizes the coverage of potential T-cell epitopes (peptides of nine amino acids) for a viral population. We found that coverage of viral diversity using mosaics was greatly increased compared to coverage by natural-sequence vaccine candidates, for both variable and conserved proteins; for conserved HIV-1 proteins, global coverage may be feasible. For example, four mosaic proteins perfectly matched 74% of 9-amino-acid potential epitopes in global Gag sequences; 87% of potential epitopes matched at least 8 of 9 positions. In contrast, a single natural Gag protein covered only 37% (9 of 9) and 67% (8 of 9). Mosaics provide diversity coverage comparable to that afforded by thousands of separate peptides, but, because the fragments of natural proteins are compressed into a small number of native-like proteins, they are tractable for vaccines. Â© 2007 Nature Publishing Group.",
            "authors": [
                "Fischer W.",
                "Perkins S.",
                "Theiler J.",
                "Bhattacharya T.",
                "Yusim K.",
                "Funkhouser R.",
                "Kuiken C.",
                "Haynes B.",
                "Letvin N.L.",
                "Walker B.D.",
                "Hahn B.H.",
                "Korber B.T."
            ],
            "cit_count": 264,
            "journal": "Nature Medicine",
            "pmid": "17187074",
            "title": "Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants",
            "year": "2007-01-01"
        }
    ],
    "summary": {
        "biotoolsCURIE": "biotools:mosaic_vaccine_designer",
        "biotoolsID": "mosaic_vaccine_designer",
        "description": "Will generate candidate vaccine protein cocktails that optimize the coverage, by a small set of mosaic proteins that could be included in a vaccine cocktail, of potential T-cell epitopes in a large diverse set of proteins.",
        "homepage": "http://www.hiv.lanl.gov/content/sequence/MOSAIC/makeVaccine.html",
        "name": "Mosaic Vaccine Designer"
    }
}